Relationships Between Plasma Lipid Species, Gender, Risk Factors, and Alzheimer’s Disease

Manuscript Number: 

19-1304R1

Author(s): 
David Ames, Ashley I. Bush, Pratishtha Chatterjee, Brian G. Drew, Corey Giles, Kevin Huynh, Kaushala Jayawardana, Simon M. Laws, Wei Ling F. Lim, Ian J. Martins, Ralph N. Martins, Colin L. Masters, Peter J. Meikle, Natalie A. Mellett, Christopher C. Rowe, Victor L. Villemagne

Disclosures

David Ames

  • Nothing to Disclose

Ashley I. Bush

  • Consulting Fees:
    Consulting fees Collaborative Medicinal Development Pty Ltd
    Equity:
    Shares: Alterity Biotechnology Ltd, Cogstate Ltd, Mesoblast Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd Profit share: Collaborative Medicinal Development LLC.

Pratishtha Chatterjee

  • Nothing to Disclose

Brian G. Drew

  • Nothing to Disclose

Corey Giles

  • Nothing to Disclose

Kevin Huynh

  • Nothing to Disclose

Kaushala Jayawardana

  • Nothing to Disclose

Simon M. Laws

  • Nothing to Disclose

Wei Ling F. Lim

  • Patents/Royalties
    A provisional patent has been filed. Application number: App Number 2018901220; DEMENTIA RISK ANALYSIS; Baker Heart and Diabetes Institute, Edith Cowan University

Ralph N. Martins

  • Patents/Royalties
    A provisional patent has been filed. Application number: App Number 2018901220; DEMENTIA RISK ANALYSIS; Baker Heart and Diabetes Institute, Edith Cowan University.

Ian J. Martins

  • Nothing to Disclose

Colin L. Masters

  • Nothing to Disclose

Peter J. Meikle

  • Patents/Royalties
    PCT filed in Australia Application number: 2018901220 Title: Dementia risk analysis This patent describes a series of plasma lipid species that may be useful in predicting risk of Alzheimer's disease.

Natalie A. Mellett

  • Nothing to Disclose

Christopher C. Rowe

  • Nothing to Disclose

Victor L. Villemagne

  • Nothing to Disclose